Searched for
CLINICAL TRIALS
Dario Amodei says AI could make cancer, Alzheimer’s ‘relics of the past’ in less than a decade as Anthropic expands AI-driven drug discovery pushAnthropic is collaborating with several pharmaceutical companies to utilize AI in drug development processes. These partnerships aim to imp...- Gym closes 15 minutes earlier than advertised time, Punjab man quits six-month membership within two months; consumer court orders gym to pay Rs 6,500An Amritsar man paid Rs 5,760 for a six-month gym membership but left within two months, alleging that they closed earlier than advertised ...
- GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...
- Does eating late really slow your metabolism? The clue came while people sleptIn a small 2026 trial, eight men ate the same meals on two different schedules. Eating late made no clear difference to how many calories t...
- US FDA adds rare vision-loss warning to popular GLP-1 drugsThe US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including O...
- Stocks in news: M&M, BHEL, Adani Enterprises, Wipro, Tata Steel, Siemens and Divi's LabsIndian equity markets ended marginally lower on Sunday, breaking a seven-session winning streak. The NSE Nifty 50 decreased by 44 points, c...
- 'Liquid biopsy can ease financial burden for cancer patients': Scientists on how a $1,000 test could save $10,000 in treatment costsLiquid biopsy, a blood-based test that detects and analyses cancer-related biomarkers, is gaining ground as a tool to monitor disease progr...
- MIT scientists built over 400 tiny ecosystems with 12 to 20 bacterial species; after adding an outsider, the more changeable communities were easier to invadeResearchers at MIT have discovered that chaotic ecosystems easily accept new species while stable ones resist invasion. Conventional ecolog...
- Scientists gave mice an existing asthma drug before exposing them to peanut extract; 95% were protected from severe allergic reactions in the experimentResearchers at Northwestern University found that the asthma drug Zileuton reduces allergic reactions in mice fed peanut extract. The study...
- The man behind Lord’s Mark: Dr. Sachidanand Upadhyay features in TIME Magazine for the third consecutive yearDr. Sachidanand Upadhyay has gained recognition from TIME Magazine for his remarkable contributions to technology and innovation. Lord’s Ma...
- Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trialPatients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than ...
- With most drug candidates failing in humans, India’s draft rules bet on the wrong science in animal lab testingRecent draft rules in India threaten advancements in non-animal testing for drug development and safety. The new regulations may prioritize...
- India leads on non-animal testing and its draft lab animal rules threaten to undo thatIndia's draft Prevention of Cruelty to Animals Rules 2026 proposes significant changes to animal research regulations and oversight. It all...
- His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccinesHyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...
- Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology se...
- UC innovations make TIME’s Best Inventions of 2026: How a pancreatic cancer drug and smarter wheelchair are changing lives?From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyo...
- Hospital balance sheet: How AI could cut costs and improve efficiencyAs hospitals grapple with soaring costs in drugs, supplies, and labor, the integration of AI emerges as a vital necessity.
- Anthropic's Claude cut Enveda's drug records' review time by 89%Colorado-based biotechnology company Enveda developed a CMC Document Processor to help reviewers identify errors, inconsistencies and poten...
- Swiss AI drug trial startup receives funding from Spotify-backer CreandumAn AI foundation model, trained on about two million human RNA readouts, would replace these and animal testing with 12-week simulations, t...
- AI halves drug discovery times, but =trial bottleneck remains a costly realityNovo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory a...
Load More
